“Click-Chemistry”-based esterization at the COOH of “Ketorolac” boosts the anti-cancer activity by over 500-fold. The anti-cancer activity was boosted in parallel with the anti-PAK1 activity. This outcome is seemingly due to a robust increase in its cell-permeability.